Waters Corporation Announces U.S. Drug Enforcement Administration Acquires Waters...

Waters Corporation Announces U.S. Drug Enforcement Administration Acquires
Waters ACQUITY UPLC System to Train Forensic Chemists in Drug Screening and
Profiling

MILFORD, Mass., April 29 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE:
WAT) announced today that the United States Drug Enforcement Administration
(U.S. DEA) purchased a Waters(R) ACQUITY(R) UltraPerformance Liquid
Chromatograph for the purpose of training new forensic chemists at the Special
Testing and Research Laboratory in Dulles, Va.

Forensic laboratories are an important resource in assisting local, state and
federal law enforcement agencies in monitoring and combating illicit drug
abuse and trafficking, including the diversion of legally-manufactured
pharmaceuticals into illegal markets. For example, data collected by the DEA
from forensic laboratories about the regional use of prescription pain
medicines like oxycodone and hydrocodone for non-medical purposes informs drug
policy and drug enforcement initiatives and helps solve crimes. Each year,
several million seized drug items are analyzed by the nation's network of
government and private forensic laboratories.

Since 2004, the DEA has applied Waters ACQUITY UltraPerformance LC(R)
(UPLC(R)) technology for drug profiling and has investigated this technology
for drug screening analyses.

For drug profiling applications, where experts analyze trace impurities such
as precursor chemicals in synthetic drugs or the constituents of natural
products such as those derived from opium, a combination of UPLC and mass
spectrometry (UPLC/MS/MS) has been shown to offer 2X better resolving power
than HPLC and greater specificity and sensitivity than HPLC paired with
photodiode array detection. These trace impurities can be important in
matching a seized drug to a particular individual and potentially linking it
to other cases where a similar impurity profile has been generated.

The DEA's most recent acquisition of an ACQUITY UPLC System complements its
growing number of Waters ACQUITY UPLC and UPLC/MS/MS analytical systems
deployed at DEA laboratories around the country.

For more information on Waters products for UPLC, visit www.waters.com/uplc.

About Waters Corporation (www.waters.com)

For 50 years, Waters Corporation (NYSE: WAT) creates business advantages for
laboratory-dependent organizations by delivering practical and sustainable
innovation to enable significant advancements in such areas as healthcare
delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an enduring platform
for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving
scientific discovery and operational excellence for customers worldwide.

Waters, ACQUITY, UPLC, UltraPerformance LC, and ACQUITY UPLC are trademarks of
Waters Corporation.

SOURCE Waters Corporation

Brian J. Murphy, Public Relations Manager of Waters Corporation,
+1-508-482-2614, brian_j_murphy@waters.com